Search

Memorial Sloan Kettering has convened a COVID-19 Operating Room Executive Committee to scrutinize all surgical cases and determine whether they were truly essential and to review needs, resources, and ICU availability.

… Monday, May 11, 2020 The COVID-19 pandemic has stressed healthcare systems globally and is presenting particular challenges to cancer surgeons and cancer surgery programs. As New York City quickly became the epicenter of the pandemic in the United States, Memorial Sloan Kettering convened an Operating

An MSK medical oncologist and geneticist discusses the latest drug approved for breast cancer and how genetic testing can lead to new treatments.

… Wednesday, February 21, 2018 Summary In this interview, Mark Robson, Chief of the Breast Medicine Service at Memorial Sloan Kettering, discusses olaparib, the latest drug approved for breast cancer, and how genetic testing can lead to new targeted therapies. Last month, the US Food and Drug Administration

Memorial Sloan Kettering Cancer Center (MSK), The Rockefeller University, and Weill Cornell Medicine today announced that they will expand the focus of the successful Tri-Institutional Therapeutics Discovery Institute, Inc. (Tri-I TDI), a partnership established in 2013 to expedite early-stage drug discovery of innovative new therapies. Under this expansion, Tri-I TDI will extend its current relationship with its industry partner, Takeda Pharmaceutical Company, Ltd. from the realm of small molecule discovery into the new research area of antibody drug discovery. All three institutions will benefit from Tri-I TDI’s expansion.

… Thursday, June 16, 2016 Memorial Sloan Kettering Cancer Center (MSK), The Rockefeller University, and Weill Cornell Medicine today announced that they will expand the focus of the successful Tri-Institutional Therapeutics Discovery Institute, Inc. (Tri-I TDI), a partnership established in 2013 to expedite

Read about a CAR T cell therapy that appears effective against light chain (AL) amyloidosis.

… Sunday, December 7, 2025 VIDEO | 02:47 Watch How CAR T Cell Therapy Eliminated a Patient’s Rare Blood Disease Every cancer breakthrough begins years before it offers patients new hope. Our series Saved by Science takes you inside MSK’s world class research labs, where you’ll see patients meet the scientists

The scientific world lost one of its greats this week. Here, we reflect on his influence.

… Friday, January 11, 2019 John Mendelsohn John Mendelsohn John Mendelsohn Dr. Mendelsohn in his lab at MSK John Mendelshon Dr. Mendelsohn in his lab at MSK Summary Former MSK physician-scientist John Mendelsohn, who served the institution in multiple roles from 1985 to 1996, died on January 7 from brain

In recognition of Breast Cancer Awareness Month, MSK shared four stories about new developments and advances in breast cancer prevention, research and treatment being conducted by MSK clinicians and researchers.

… Wednesday, October 20, 2021 In recognition of Breast Cancer Awareness Month, Memorial Sloan Kettering Cancer Center (MSK) shared four stories about new developments and advances in breast cancer prevention, research and treatment being conducted by MSK clinicians and researchers. The COVID-19 pandemic

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the American Association for Cancer Research (AACR) Annual Meeting on April 14-19 in Orlando, Florida.

… Wednesday, April 12, 2023 Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the American Association for Cancer Research (AACR) Annual Meeting on April

Fifth-year graduate student Semanti Mukherjee was awarded the Chairman's Prize for her first-author paper that was accepted for publication in the May 2011 issue of Human Heredity.

… Monday, August 1, 2011 Semanti Mukherjee, a fifth-year graduate student in Robert Klein’s lab in the Cancer Biology and Genetics Program, was awarded the Chairman’s Prize for her first-author paper  Including additional controls from public databases improves the power of a genome-wide association study

MSK patients that need urgent care may receive care closer to home. That’s when MSK's 34 Shared Care nurses — led by Carol Gemignani — step in.

… Thursday, May 12, 2022 If the Shared Care Nursing team at Memorial Sloan Kettering Cancer Center had a theme song, it could be Randy Newman’s “You’ve Got a Friend in Me.” MSK patients that need urgent care may receive care closer to home. That’s when MSK’s 34 Shared Care nurses — led by Carol Gemignani

New MSK research uncovers new details of the immune response against leptomeningeal metastasis; develops a grading system to assess the risk of developing thrombocytopenia after CAR T cell therapy; and outlines a method for scientists to estimate metabolic characteristics from challenging clinical samples.

… Monday, May 19, 2025 New research from Memorial Sloan Kettering Cancer Center (MSK) uncovers new details of the immune response against leptomeningeal metastasis; develops a grading system to assess the risk of developing thrombocytopenia after CAR T cell therapy; outlines a method for scientists to